In conclusion, our study demonstrates that ZNF32 is highly expressed in colorectal CSCs, promotes the self-renewal capacity of colorectal CSCs and is associated with the clinical prognosis of CRC patients. This evidence concerns the gene ZNF32 and colorectal carcinoma.